Yadav A - Search Results

1

YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.

Kumar B, Yadav A, Lang JC, Cipolla MJ, Schmitt AC, Arradaza N, Teknos TN, Kumar P. Kumar B, et al. Among authors: yadav a. Mol Cancer Ther. 2012 Sep;11(9):1988-98. doi: 10.1158/1535-7163.MCT-12-0167. Epub 2012 Jun 21. Mol Cancer Ther. 2012. PMID: 22723337 Free PMC article.

2

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Kumar P, Yadav A, Patel SN, Islam M, Pan Q, Merajver SD, Teknos TN. Kumar P, et al. Among authors: yadav a. Mol Cancer. 2010 Aug 3;9:206. doi: 10.1186/1476-4598-9-206. Mol Cancer. 2010. PMID: 20682068 Free PMC article.

3

Sorafenib enhances the antitumor effects of chemoradiation treatment by downregulating ERCC-1 and XRCC-1 DNA repair proteins.

Yadav A, Kumar B, Teknos TN, Kumar P. Yadav A, et al. Mol Cancer Ther. 2011 Jul;10(7):1241-51. doi: 10.1158/1535-7163.MCT-11-0004. Epub 2011 May 6. Mol Cancer Ther. 2011. PMID: 21551262 Free PMC article.

4

IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.

Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. Yadav A, et al. Mol Cancer Res. 2011 Dec;9(12):1658-67. doi: 10.1158/1541-7786.MCR-11-0271. Epub 2011 Oct 5. Mol Cancer Res. 2011. PMID: 21976712 Free PMC article.

5

Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.

Kumar B, Yadav A, Lang J, Teknos TN, Kumar P. Kumar B, et al. Among authors: yadav a. PLoS One. 2012;7(5):e37601. doi: 10.1371/journal.pone.0037601. Epub 2012 May 22. PLoS One. 2012. PMID: 22629428 Free PMC article.

6

A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.

Kumar B, Yadav A, Hideg K, Kuppusamy P, Teknos TN, Kumar P. Kumar B, et al. Among authors: yadav a. PLoS One. 2014 Mar 27;9(3):e93208. doi: 10.1371/journal.pone.0093208. eCollection 2014. PLoS One. 2014. PMID: 24675768 Free PMC article.

7

Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog.

Kumar B, Yadav A, Lang JC, Teknos TN, Kumar P. Kumar B, et al. Among authors: yadav a. Genes Cancer. 2015 Mar;6(3-4):169-81. doi: 10.18632/genesandcancer.54. Genes Cancer. 2015. PMID: 26000099 Free PMC article.

8

A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.

Yadav A, Kumar B, Lang JC, Teknos TN, Kumar P. Yadav A, et al. Oncogene. 2017 Nov 16;36(46):6374-6382. doi: 10.1038/onc.2017.245. Epub 2017 Jul 24. Oncogene. 2017. PMID: 28745314 Free PMC article.

9

Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis.

Yadav A, Kumar B, Yu JG, Old M, Teknos TN, Kumar P. Yadav A, et al. PLoS One. 2015 Oct 28;10(10):e0141602. doi: 10.1371/journal.pone.0141602. eCollection 2015. PLoS One. 2015. PMID: 26509633 Free PMC article.

10

Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.

Kumar B, Yadav A, Brown NV, Zhao S, Cipolla MJ, Wakely PE, Schmitt AC, Baiocchi RA, Teknos TN, Old M, Kumar P. Kumar B, et al. Among authors: yadav a. Oncotarget. 2017 Feb 28;8(9):14847-14859. doi: 10.18632/oncotarget.14682. Oncotarget. 2017. PMID: 28107179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,492 results

Search Page

Filters